Alteri Wealth’s AbbVie ABBV Stock Holding History

Alteri Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.31M	Sell	5,225 -1,192	-19%	-$256K	0.36%	60
2026 Q1	$1.4M	Buy	6,417 +268	+4%	+$59.4K	0.45%	42
2025 Q4	$1.41M	Buy	6,149 +602	+11%	+$137K	0.46%	42
2025 Q3	$1.28M	Buy	5,547 +21	+0.4%	+$4.28K	0.44%	49
2025 Q2	$1.03M	Sell	5,526 -1,528	-22%	-$284K	0.4%	57
2025 Q1	$1.48M	Buy	7,054 +208	+3%	+$40.4K	0.65%	30
2024 Q4	$1.22M	Buy	+6,846	New	+$1.26M	0.34%	41

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Alteri Wealth's ABBV Position: Q2 2026 in Review

Alteri Wealth reduced its AbbVie (ABBV) stake by 19% in Q2 2026, selling an estimated $256K and leaving 5,225 shares worth $1.31M. The position accounts for 0.36% of the portfolio, ranked #60.

Alteri Wealth first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.48M in Q1 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Alteri Wealth held 5,225 shares of AbbVie worth $1.31M as of Q2 2026.
Alteri Wealth sold 1,192 AbbVie shares in Q2 2026, an estimated $256K.
AbbVie made up 0.36% of Alteri Wealth's portfolio in Q2 2026, its #60 holding.
Alteri Wealth first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Alteri Wealth's AbbVie position peaked at $1.48M in Q1 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alteri Wealth's 13F filing for Q2 2026, filed 29 Jul 2026.